curcumin-c3-complex.pdf
of 7
-
Upload
gopalakrishnan-sivaraman -
Category
Documents
-
view
220 -
download
0
Transcript of curcumin-c3-complex.pdf
-
8/10/2019 curcumin-c3-complex.pdf
1/7
Product Presentation
Sabinsa Corporation
Sabinsa Corporation
-
8/10/2019 curcumin-c3-complex.pdf
2/7
Source: Curcuma lon a(Turmeric)
Active components:urcum no s
Nutraceutical applications
Anti-inflammatory support
Immune su ort Plant part used: Roots
U.S. PATENT #5,861,415 (1999)
Sabinsa Corporation
INTERNATIONAL PATENT: European Patent # EP0839037 (2002)www.curcuminoids.com I www.curcuminc3complex.com
2
-
8/10/2019 curcumin-c3-complex.pdf
3/7
Beneficial Effects
of Curcuminoids Curcumin C3 Complex is an effective "Bioprotectant, antioxidant
quenching free radicals and also preventing their formation 1
urcum n as een s own to e a - yc ooxygenase- n tor
Unlike conventional non steroidal anti-inflammatory drugs (NSAIDs),
Curcuminoids support a healthy immune system 1
Prevent connective tissue break down through inhibiting destructiveenzymes 2
1
Sabinsa Corporation
2 Liacini, A. et al. Matrix Biol. 2002 Apr;21(3):251-62
3
-
8/10/2019 curcumin-c3-complex.pdf
4/7
Nutraceutical Applications
o urcum no ds Antioxidant support
Alzheimers disease/dementia
Cardiovascular support
- , -
Wound healing
, ,colorectal cancer, bladder cancer, oral leucoplakia, psoriasis, antiviraleffects.
Sabinsa Corporation 4
-
8/10/2019 curcumin-c3-complex.pdf
5/7
PHARMACOLOGY &
1. Curcumin/Piperine - IND study approved: IND# 61,872
-Food & Drug Administration Office of Drug Evaluation I, Division ofOncology Drug Products
2. The effects of Curcuminoids on aberrant crypt foci in the human colon:IND# 51,685- UMDNJ- Robert Wood Johnson Medical School, New Jersey CancerInst tute
3. Pilot study of curcuminoids with or without BioPerine in patients with,
- MD Anderson Cancer Center, University of Texas
'
Sabinsa Corporation
. - University of California, Los Angeles
5
-
8/10/2019 curcumin-c3-complex.pdf
6/7
PHARMACOLOGY &
5. Curcuminoids in atients with Lichen lanus: IND#65 700/S-000
con
- University of California
6. Phase IIa prevention study of C3 Complex curcuminoids in women atincreased risk for breast cancer- MD Anderson Cancer Center, University of Texas
7. The cl n cal and laboratory e ects o top cal curcum no ds n pat entswith normal skin and with dysplastic and benign nevi- National Cancer Institute
9. Phase II prevention study with C3 Complex in patients withcolorectal cancer stage I-III-
Sabinsa Corporation
, ,
6
-
8/10/2019 curcumin-c3-complex.pdf
7/7
PHARMACOLOGY &
10. Phase I trial of C3 Com lex and recoo erative atients with locall
con
advanced esophageal or gastroesophageal carcinoma- MD Anderson Cancer Center, University of Texas
11. Metabolic studies and chemopreventive studies-University of Leicester, UK
For more information:
Tel: +1-732-777-1111- - -
E-mail: [email protected]
Sabinsa Corporation
. .Website: www.curcuminoids.comWebsite: www.curcuminc3complex.com
7
